Connection
Breelyn Wilky to Liposarcoma
This is a "connection" page, showing publications Breelyn Wilky has written about Liposarcoma.
|
|
Connection Strength |
|
 |
|
 |
|
0.420 |
|
|
|
-
Ludwig MP, Galbraith MD, Eduthan NP, Hill AA, Clay MR, Tellez CM, Wilky BA, Elias A, Espinosa JM, Sullivan KD. Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway. Cancer Res. 2023 08 01; 83(15):2543-2556.
Score: 0.218
-
Moreno Tellez C, Leyfman Y, D'Angelo SP, Wilky BA, Dufresne A. Immunotherapy in Sarcoma: Where Do Things Stand? Surg Oncol Clin N Am. 2022 07; 31(3):381-397.
Score: 0.202